Vanguard Group’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1M | Sell |
1,157,317
-150,449
| -12% | -$403K | ﹤0.01% | 3377 |
|
|
2025
Q1 | $5.6M | Sell |
1,307,766
-9,804
| -0.7% | -$42K | ﹤0.01% | 3124 |
|
|
2024
Q4 | $5.27M | Buy |
1,317,570
+7,767
| +0.6% | +$31.1K | ﹤0.01% | 3248 |
|
|
2024
Q3 | $6.73M | Buy |
1,309,803
+20,822
| +2% | +$107K | ﹤0.01% | 3137 |
|
|
2024
Q2 | $10.5M | Buy |
1,288,981
+60,634
| +5% | +$494K | ﹤0.01% | 2885 |
|
|
2024
Q1 | $6.47M | Buy |
1,228,347
+1,065
| +0.1% | +$5.61K | ﹤0.01% | 3186 |
|
|
2023
Q4 | $11.2M | Sell |
1,227,282
-18,827
| -2% | -$172K | ﹤0.01% | 2884 |
|
|
2023
Q3 | $10.9M | Buy |
1,246,109
+1,053,937
| +548% | +$9.19M | ﹤0.01% | 2835 |
|
|
2023
Q2 | $1.35M | Buy |
192,172
+88,043
| +85% | +$616K | ﹤0.01% | 3803 |
|
|
2023
Q1 | $2.04M | Buy |
+104,129
| New | +$2.04M | ﹤0.01% | 3666 |
|